These findings suggest that KL acts as a tumor suppressor by inhibiting the PI3K/Akt/GDK3β/Snail pathway, which suppresses epithelial-mesenchymal transition, tumor migration, and invasion, which contributes to RCC progression [133]. The gene discussed is SNAI1; the disease is neoplasm.